Clinical trial
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating…
NCT00004188 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00004188 |
|---|---|
| Title | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma |
| Official title | A Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplant Following Dose Intensive Induction Therapy for High Risk Neuroblastoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, carboplatin, cisplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, isotretinoin, melphalan, topotecan hydrochloride, vincristine sulfate and 5 more |
| Enrollment | 495 |
| Start date | Feb 1, 2001 |
| Primary completion | Oct 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | May 17, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: